Skip to main content
. 2022 Mar 31;15(4):435. doi: 10.3390/ph15040435

Figure 5.

Figure 5

Dissolution release profile from 3D-printed minitablets containing ritonavir or lopinavir and the commercially available formulation (Kaletra). Key: ritonavir 3D printed minitablets (-■-), lopinavir 3D printed minitablets (-▲-), ritonavir from Kaletra tablets (-●-), and lopinavir from Kaletra tablets (-▼-). * Statistical differences (p < 0.05) between ritonavir from Kaletra tablets and 3D-printed minitablets. # Statistical differences (p < 0.05) between lopinavir from Kaletra tablets and 3D-printed minitablets.